Pax7 pioneer factor action requires both paired and homeo DNA binding domains
Audrey PelletieriD, Alexandre MayraniD, Arthur GouhieriD, James G. OmichinskiiD, Aurélio BalsalobreiD, Jacques DrouiniD
Abstract
The pioneer transcription factor Pax7 contains two DNA binding domains (DBD), a paired and a homeo domain. Previous work on Pax7 and the related Pax3 had shown that each DBD can bind a cognate DNA sequence, thus defining two targets of binding and possibly modalities of action. Genomic targets of Pax7 pioneer action leading to chromatin opening are enriched for composite DNA target sites containing juxtaposed binding sites for both paired and homeo domains. The present work investigated the implication of both DBDs in pioneer action. We now show that the composite sequence is a higher affinity Pax7 binding site compared to either paired or homeo binding sites and that efficient binding to this site involves both DBDs. We also show that a Pax7 monomer binds composite sites and that methylation of cytosines within the binding site does not affect binding, which is consistent with pioneer action exerted at methylated DNA sites within nucleosomal heterochromatin. Finally, introduction of single amino acid mutations in either the paired or homeo domain that impair binding to cognate DNA sequences showed that both DBDs must be intact for pioneer action. In contrast, only the paired domain is required for low affinity binding of heterochromatin sites. Thus, Pax7 pioneer action on heterochromatin requires unique protein:DNA interactions that are more complex compared to its simpler DNA binding modalities at accessible enhancer target sites. Significance StatementPioneer transcription factors have the unique ability to recognize DNA target sites within closed heterochromatin and to trigger chromatin opening. Only a fraction of the heterochromatin recruitment sites of pioneers are subject to chromatin opening. The molecular basis for this selectivity is unknown and the present work addressed the importance of DNA sequence affinity for selection of sites to open. The pioneering ability of the pioneer factor Pax7 is not strictly determined by affinity or DNA sequence of binding sites, nor by number or methylation status of DNA sites. Mutation analyses showed that recruitment to heterochromatin is primarily dependent on the Pax7 paired domain whereas the ability to open chromatin requires both paired and homeo DNA binding domains.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 31
- FWCI
- 1.41
- Field percentile
- top 19%
- Assay
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Chromatin opening ability of pioneer factor Pax7 depends on unique isoform and C-terminal domain
Virginie Bascunana, Audrey Pelletier, … Jacques Drouin·Nucleic Acids ResearchPeer-reviewed·Jun 3, 2023
- Pioneer factor Pax7 initiates two-step cell-cycle dependent chromatin opening
Arthur Gouhier, Justine Dumoulin-Gagnon, … Jacques Drouin·Nature Structural & Molecular BiologyPeer-reviewed·Jan 1, 2024
- Pioneer and nonpioneer cooperation drives lineage specific chromatin opening
Alexandre Mayran, Kevin Sochodolsky, … Jacques Drouin·Nature CommunicationsPeer-reviewed·Aug 23, 2019
- The PAX3 and 7 homeodomains have evolved unique determinants that influence DNA-binding, structure and communication with the paired domain
G. N. Corry, B. D. Sykes, D. A. Underhill·bioRxiv·Jul 14, 2019
- Protein-intrinsic properties and context-dependent effects regulate pioneer-factor binding and function
Tyler J. Gibson, Elizabeth D. Larson, Melissa M. Harrison·Nature Structural & Molecular BiologyPeer-reviewed·Feb 16, 2024
- Chromatin compartments define distinct modes of action and biological roles of the pioneer Pax7
Arthur Gouhier, Juliette Harris, … Jacques Drouin·bioRxiv·Aug 25, 2026